These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7229949)

  • 1. In vivo kinetics of magnetically targeted low-dose doxorubicin.
    Senyei AE; Reich SD; Gonczy C; Widder KJ
    J Pharm Sci; 1981 Apr; 70(4):389-91. PubMed ID: 7229949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Microencapsul; 1990; 7(1):85-94. PubMed ID: 2308056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
    Widder KJ; Morris RM; Poore GA; Howard DP; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):135-9. PubMed ID: 6682771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
    Gupta PK; Hung CT
    Life Sci; 1990; 46(7):471-9. PubMed ID: 2304381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.
    Gallo JM; Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
    Widder KJ; Morris RM; Poore G; Howard DP; Senyei AE
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):579-81. PubMed ID: 6941258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labeled with doxorubicin or protein A.
    Rettenmaier MA; Stratton JA; Berman ML; Senyei A; Widder K; White DB; DiSaia PJ
    Gynecol Oncol; 1987 May; 27(1):34-43. PubMed ID: 3570048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The consequences of doxorubicin quinone reduction in vivo in tumour tissue.
    Cummings J; Willmott N; Hoey BM; Marley ES; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2165-74. PubMed ID: 1472081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats.
    Gupta PK; Hung CT; Rao NS
    J Pharm Sci; 1989 Apr; 78(4):290-4. PubMed ID: 2724092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.
    Widder KJ; Marino PA; Morris RM; Howard DP; Poore GA; Senyei AE
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):141-7. PubMed ID: 6682772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers.
    Leakakos T; Ji C; Lawson G; Peterson C; Goodwin S
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):445-50. PubMed ID: 12802508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; Carmichael D; Harris M; Roh JK
    Cancer Res; 1986 May; 46(5):2295-9. PubMed ID: 3697976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.
    Senyei AE; Widder KJ
    Gynecol Oncol; 1981 Aug; 12(1):1-13. PubMed ID: 7024051
    [No Abstract]   [Full Text] [Related]  

  • 15. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy.
    Siegal T; Horowitz A; Gabizon A
    J Neurosurg; 1995 Dec; 83(6):1029-37. PubMed ID: 7490617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier.
    Goodwin SC; Bittner CA; Peterson CL; Wong G
    Toxicol Sci; 2001 Mar; 60(1):177-83. PubMed ID: 11222884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of targeting efficiency of Adriamycin hydrochloride magnetic microspheres.
    Peng B; Yang X; Li X; Pan H; Zhang Z; Liu H; Ma S; Pan W
    Drug Deliv; 2011 Feb; 18(2):166-72. PubMed ID: 21047168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier.
    Nowicka AM; Kowalczyk A; Donten M; Krysinski P; Stojek Z
    Anal Chem; 2009 Sep; 81(17):7474-83. PubMed ID: 19663451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified method for preparation of adriamycin carried by magnetic albumin microspheres.
    Ma J; Chen D; Tian Y
    J Tongji Med Univ; 2001; 21(3):233-5. PubMed ID: 12539586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat.
    Gallo JM; Hung CT; Gupta PK; Perrier DG
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):305-26. PubMed ID: 2810070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.